Cooperative Agreement 2P2CMS332033
- The North Carolina Department of Health and Human Services (NC DHHS) was awarded a $558,941 cooperative agreement from the Centers for Medicare and Medicaid Services (CMS) under the Cell and Gene Therapy (CGT) Access Model program (CFDA 93.885). The funding will support a set of activities aimed at ensuring the successful implementation of the CGT Access Model in North Carolina, with the overarching goal of strengthening the state's capacity to provide access to cell and gene therapies for...
- The Department of Health Care Finance (DHCF), the state Medicaid agency for the District of Columbia, received a $1,606,299.52 Cooperative Agreement from the Centers for Medicare and Medicaid Services (CMS) under the "Section 206 Consolidated Appropriations Act, 2024: State Planning Grants to Promote Continuity of Care for Medicaid & CHIP Beneficiaries" program (CFDA 93.694). The funding will support DHCF's efforts to: 1) Improve eligibility and enrollment processing to ensure...
- The Illinois Department of Healthcare and Family Services (HFS) was awarded a $794,800 Cooperative Agreement under the Centers for Medicare and Medicaid Services' (CMS) Cell and Gene Therapy (CGT) Access Model (CFDA 93.885). The award will fund HFS staff to implement the CGT Access Model, conduct research to evaluate Medicaid customer access to sickle cell disease CGTs and the effectiveness of wraparound services, and support Community-Based Organizations (CBOs) to provide education,...
- The District of Columbia Department of Health Care Finance (DHCF) has been awarded a $4,000,000 Cooperative Agreement under the Transforming Maternal Health (TMaH) Model, a 10-year federal grant program (CFDA 93.869) administered by the Centers for Medicare and Medicaid Services (CMS). Through this award, DHCF aims to improve maternal health outcomes and address disparities in the District, particularly for women of color and those in concentrated geographical regions. The funding will enable...
- The Pennsylvania Department of Human Services (DHS) was awarded a $794,800 Cooperative Agreement from the Centers for Medicare and Medicaid Services (CMS) under the federal Cell and Gene Therapy (CGT) Access Model program (CFDA 93.885). The funding will be used to provide additional services, education, and supports for Medicaid beneficiaries who may be candidates for sickle cell disease gene therapy. DHS will collaborate with the Pennsylvania Department of Health's Sickle Cell Disease...
- The Department of Social Services Connecticut was awarded a $7,404,199 Cooperative Agreement by the Centers for Medicare and Medicaid Services under the Cell and Gene Therapy (CGT) Access Model (CFDA 93.885) to increase access to cell and gene therapy for Medicaid members with sickle cell disease in Connecticut. Key activities include: Developing educational materials and raising awareness about cell and gene therapies through collaborations with a community-based organization and four...
- The Mississippi Division of Medicaid (DOM) was awarded a $4,912,944 Cooperative Agreement from the Centers for Medicare and Medicaid Services (CFDA 93.885 - Cell and Gene Therapy (CGT) Access Model) to transform healthcare for Medicaid beneficiaries living with sickle cell disease. The funding will support five key initiatives over a 10-year period from August 2025 to December 2035: 1) Travel support for patients and caregivers to access treatment, 2) Individualized care coordination to guide...
- The Department of Health and Human Services Centers for Medicare and Medicaid Services awarded a $140.35 million Block Grant to the District of Columbia Government Health Department on October 1, 2021 through December 31, 2021. The grant funding supports the Children's Health Insurance Program (CHIP) federal grant program (CFDA #93.767), which aims to provide child health assistance to uninsured, low-income children and pregnant women. As the awardee, the District of Columbia Health Department...
- The Department of Health and Human Services Centers for Medicare and Medicaid Services awarded $3.5 million under the Medical Assistance Program (CFDA 93.778) Block Grant to the District of Columbia Government Health Department for fiscal year 2022. This funding will support the District of Columbia's Medicaid program by providing financial assistance for medical services delivered from October 1, 2021 through September 30, 2022. As the official description notes, the Medical Assistance...
- The District of Columbia Government, through its District of Columbia Department of Health (DC Health), has been awarded a $59,297,830 federal Block Grant under the Children's Health Insurance Program (CHIP - CFDA 93.767) by the Centers for Medicare and Medicaid Services (CMS). This grant, which covers the period from October 1, 2023 to December 31, 2023, will enable DC Health to maintain and expand health insurance coverage for uninsured, low-income children and pregnant women in the District...
The Department of Health Care Finance (DHCF), the District of Columbia's state Medicaid agency, was awarded a $7,072,261 cooperative agreement by the Centers for Medicare and Medicaid Services (CFDA #93.885 Cell and Gene Therapy (CGT) Access Model) on August 1, 2025. The funding will support DHCF's implementation of the CGT Access Model, which aims to improve access to cell and gene therapies, particularly for sickle cell disease patients. The grant will enable DHCF to: 1) build internal capacity to participate in the model, 2) provide direct support to patients and their families accessing new cell and gene therapies, and 3) increase community awareness and engagement around access to these transformative treatments. The award funding will be used over a 10-year performance period, with a final completion date of December 31, 2035.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $565.4k | 8/1/25 |